Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03863834 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of RFAL of Breast Envelope and NAC Position

A NA study, sponsored by InMode MD.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT03863834: Completed NA study, sponsored by InMode MD.

NCT03863834 is a NA study that has completed, run by InMode MD. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03863834, a NA study, has completed, sponsored by InMode MD.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This single center clinical study is intended to determine the safety and efficacy of using Radiofrequency (RF) energy for minimally invasive breast lift procedure.

Primary Outcome

Regular and 3D Vectra photos will be taken at all time points. Additional evaluation of changes in breast shape, including upper pole fullness, breast projection, and bottoming out will be assessed by static measurements (cm) of: * Sternal Notch to Nipple * Nipple to Inframammary Fold (IMF) * Base Width (at point of breast take off from chest wall) * Nipple to nipple

Interventions

  • DEVICE InModeRF

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-10-13
Est. Completion 2020-04-01
Phase NA
InMode MD

22 total trials

What the finished NCT03863834 record still lists

NCT03863834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which InModeRF is the first listed.

NCT03863834 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03863834 about?

NCT03863834 is a clinical study titled "Clinical Evaluation of RFAL of Breast Envelope and NAC Position". This single center clinical study is intended to determine the safety and efficacy of using Radiofrequency (RF) energy for minimally invasive breast lift procedure.

What is the current status of trial NCT03863834?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-10-13. Estimated completion is 2020-04-01.

What interventions are being tested in trial NCT03863834?

The interventions under investigation include: InModeRF (DEVICE).

Who is sponsoring clinical trial NCT03863834?

This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03863834's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03863834, the US trial registry maintained by the National Library of Medicine. NCT03863834 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.